Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1753–1776 of 8,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Herpes Zoster
Interventions: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A); Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 65 Years and older
Enrollment: 430 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 32
States / cities: Huntsville, Alabama • Daly City, California • Los Gatos, California + 27 more

Conditions: Chickenpox
Interventions: Candidate varicella vaccine, Marketed varicella vaccine, MMR vaccine, Hepatitis A vaccine, PCV (pneumococcal conjugate vaccine) 13, PCV 20, Vaxneuvance; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Months to 15 Months
Enrollment: 911 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 13
States / cities: Tucson, Arizona • Huntington Park, California • Sherman Oaks, California + 10 more

Conditions: Childhood Cancer
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: COVID-19, Influenza A, Influenza B
Interventions: MGC Health COVID-19 & Flu A+B Home Multi Test, MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o); Diagnostic Test
Lead sponsor: Medical Group Care, LLC; Industry
Eligibility: 2 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Exercise-induced Bronchospasm
Interventions: Levalbuterol tartrate HFA MDI, Placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 2
States / cities: Denver, Colorado • Burke, Virginia

Conditions: Covid19, Vaccine Acceptability
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 1,208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Acne
Interventions: Acne mRNA vaccine, Placebo; Biological · Other
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 79
States / cities: Scottsdale, Arizona • Cerritos, California • Encino, California + 64 more

Conditions: Aging
Interventions: MitoQ, Placebo; Drug
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 60 Years to 79 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Influenza
Interventions: Peramivir, Oseltamivir; Drug
Lead sponsor: BioCryst Pharmaceuticals; Industry
Eligibility: 0 Days to 17 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 9
States / cities: Shreveport, Louisiana • Dayton, Ohio • Smithfield, Pennsylvania + 6 more

Conditions: Leukemia
Interventions: cyclosporine, gemtuzumab ozogamicin; Drug
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 60 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Weight
Interventions: Mercy TAPE; Device
Lead sponsor: Susan Abdel-Rahman; Other
Eligibility: 2 Months to 16 Years
Enrollment: 642 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 3
States / cities: Little Rock, Arkansas • Kansas City, Missouri • Hershey, Pennsylvania

Conditions: Infection, Human Immunodeficiency Virus, HIV Infections
Interventions: GW433908, ritonavir; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 4 Weeks to 2 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2022
U.S. locations: 2
States / cities: Jacksonville, Florida • Durham, North Carolina

Conditions: Obesity, Body Weight
Interventions: DGA Mediterranean diet pattern, energy balance, DGA Mediterranean diet pattern, negative energy balance, TAD diet pattern, negative energy balance; Other
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 19 Years to 64 Years · Female only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Davis, California

Conditions: Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma, Familial Pancreatic Cancer, BRCA 1/2, HNPCC, Lynch Syndrome, Hereditary Pancreatitis, FAMMM, Familial Atypical Multiple Mole Melanoma, Peutz Jeghers Syndrome
Interventions: Endoscopic Ultrasound, Magnetic Resonance Imaging (MRI); Procedure
Lead sponsor: White Plains Hospital; Other
Eligibility: 18 Years and older
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Cardiovascular Disease, Aging
Interventions: Exercise-Training Program; Behavioral
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 55 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Geographic Atrophy
Interventions: APL-2, Sham Procedure; Drug · Other
Lead sponsor: Apellis Pharmaceuticals, Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 67
States / cities: Phoenix, Arizona • Bakersfield, California • Beverly Hills, California + 56 more

Conditions: Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Interventions: Breast Cancer Treatment Decision Aid for women 70+, Usual Care; Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 70 Years and older · Female only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Brain Concussion
Interventions: Aerobic Exercise, Non-Aerobic Exercise; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 40 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cancer
Interventions: Core Intervention, E-Coach, General Mindfulness Training, MVPA-Specific Mindfulness Training, Buddy; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois • Winston-Salem, North Carolina

Conditions: Geographic Atrophy, Age-Related Macular Degeneration
Interventions: ABBV-6628, SYFOVRE; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 50 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 5
States / cities: Carmel, Indiana • Reno, Nevada • Abilene, Texas + 2 more

Conditions: Fetal Alcohol Spectrum Disorders
Interventions: CARRII, CARRII Education; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Asthma
Interventions: albuterol sulfate inhalation aerosol; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: Up to 23 Months
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 27
States / cities: Hoover, Alabama • Fort Mohave, Arizona • Jonesboro, Arkansas + 24 more

Conditions: Breast Cancer, Cognitive/Functional Effects, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults
Interventions: assessment of therapy complications, cognitive assessment, fatigue assessment and management; Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Stroke, Cerebral Palsy
Interventions: Bi-ADLER; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 19 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

Feasibility of Isolating P16 Expression

MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB

Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults

Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza

Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia

Validation of the Mercy TAPE

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

Metabolic and Bio-behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans

Pancreatic Cancer Early Detection Program

Effects of Age and Exercise on Blood Pressure Regulation

A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

The Effect of Exercise on Neurorecovery Following Mild Traumatic Brain Injury

Optimization of a mHealth Physical Activity Promotion Intervention With Mindful Awareness for AYAO (OPT2MOVE)

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Contraception and Alcohol Risk Reduction Internet Intervention Randomized Trial

Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children

Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers

Usability Testing of a Bilateral Activities of Daily Exercise Robot for Stroke Therapy